Pulmonary hypertension in valvular disease: A comprehensive review on pathophysiology to therapy from the HAVEC group

JACC: Cardiovascular Imaging

Volumn 8, Issue 1, 2015, Pages 83-99

  Magne, Julien ^a   Pibarot, Philippe ^b   Sengupta, Partho P ^c   Donal, Erwan ^d   Rosenhek, Raphael ^e   Lancellotti, Patrizio ^f,g  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b LAVAL UNIVERSITY   (Canada)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d UNIVERSITÉ DE RENNES 1   (France)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f UNIVERSITY OF LIÈGE   (Belgium)

^g GVM Care and Research   (Italy)

Author keywords

Cardiovascular imaging; Exercise echocardiography; Pulmonary hypertension; Therapy; Valve

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; MICRORNA; MICRORNA 126; MICRORNA 208; MYOCYTE ENHANCER FACTOR 2; PROTEIN KINASE PIM 1; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG;

AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; CARDIAC IMAGING; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR SYSTEM EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY ASSESSMENT; DOPPLER ECHOCARDIOGRAPHY; EXERCISE; HEART CATHETERIZATION; HEART LEFT ATRIUM PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART RIGHT VENTRICLE; HEART STROKE VOLUME; HEART VALVE REPLACEMENT; HEART VENTRICLE FUNCTION; HUMAN; KINESIOTHERAPY; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MITRAL ANNULOPLASTY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE STENOSIS; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; RISK ASSESSMENT; STRESS ECHOCARDIOGRAPHY; THORAX RADIOGRAPHY; THREE DIMENSIONAL ECHOCARDIOGRAPHY; TRICUSPID VALVE; TRICUSPID VALVE STENOSIS; VALVULAR HEART DISEASE; COMPLICATION; ECHOCARDIOGRAPHY; HEART VALVE DISEASES; HYPERTENSION, PULMONARY;

BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; HEART VALVE DISEASES; HUMANS; HYPERTENSION, PULMONARY; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE STENOSIS; PHYSICAL EXERTION;

EID: 84922502827     PISSN: 1936878X     EISSN: 18767591     Source Type: Journal    
DOI: 10.1016/j.jcmg.2014.12.003     Document Type: Review

References (85)

1. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009;34:1219-63.
2. Fang JC, DeMarco T, Givertz MM, et al. World Health Organization Pulmonary Hypertension Group 2: pulmonary hypertension due to left heart disease in the adult-a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2012;31: 913-33.
3. Vachiery JL, Adir Y, Barbera JA, et al. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol 2013;62:D100-8.
4. Snopek G, Pogorzelska H, Rywik TM, Browarek A, Janas J, Korewicki J. Usefulness of endothelin-1 concentration in capillary blood in patients with mitral stenosis as a predictor of regression of pulmonary hypertension after mitral valve replacement or valvuloplasty. Am J Cardiol 2002;90:188-9.
5. Guazzi M, Arena R. Pulmonary hypertension with left-sided heart disease. Nat Rev Cardiol 2010;64:648-59.
6. Lancellotti P, Budts W, De WD, et al. Practical recommendations on the use of echocardiography to assess pulmonary arterial hypertension-a Belgian expert consensus endorsed by the Working Group on Non-Invasive Cardiac Imaging. Acta Cardiol 2013;68:59-69.
7. Habib G, Torbicki A. The role of echocardiography in the diagnosis and management of patients with pulmonary hypertension. Eur Respir Rev 2010;19:288-99.
8. Lang RM, Badano L, Afilalo J, et al. Recommendations for cardiac chamber quantification by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2014. In press.
9. Waxman AB. Exercise physiology and pulmonary arterial hypertension. Prog Cardiovasc Dis 2012;55:172-9.
10. Magne J, Lancellotti P, Pierard LA. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation 2010;122: 33-41.
11. Lancellotti P, Magne J, Donal E, et al. Determinants and prognostic significance of exercise pulmonary hypertension in asymptomatic severe aortic stenosis. Circulation 2012;126:851-9.
12. Tolle JJ, Waxman AB, Van Horn TL, Pappagianopoulos PP, Systrom DM. Exerciseinduced pulmonary arterial hypertension. Circulation 2008;118:2183-9.
13. Lewis GD, Murphy RM, Shah RV, et al. Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes. Circ Heart Fail 2011;4:276-85.
14. Mahjoub H, Levy F, Cassol M, et al. Effects of age on pulmonary artery systolic pressure at rest and during exercise in normal adults. Eur J Echocardiogr 2009;10:635-40.
15. Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713.
16. Badano LP, Ginghina C, Easaw J, et al. Right ventricle in pulmonary arterial hypertension: haemodynamics, structural changes, imaging, and proposal of a study protocol aimed to assess remodelling and treatment effects. Eur J Echocardiogr 2010;11:27-37.
17. Kawut SM, Lima JA, Barr RG, et al. Sex and race differences in right ventricular structure and function: the Multi-Ethnic Study of Atherosclerosis- Right Ventricle study. Circulation 2011;123: 2542-51.
18. Lancellotti P, Tribouilloy C, Hagendorff A, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2013;14:611-44.
19. Faggiano P, Antonini-Canterin F, Ribichini F, et al. Pulmonary artery hypertension in adult patients with symptomatic valvular aortic stenosis. Am J Cardiol 2000;85:204-8.
20. Buonanno C, Johnson LW, Bowser MA, Hapanowicz MB, Marvasti M, Parker FB. Pulmonary hypertension in severe aortic stenosis: incidence, mechanisms, clinical and surgical implications. G Ital Cardiol 1987;17:636-41.
21. Silver K, Aurigemma G, Krendel S, Barry N, Ockene I, Alpert J. Pulmonary artery hypertension in severe aortic stenosis: incidence and mechanism. Am Heart J 1993;125:146-50.
22. Kapoor N, Varadarajan P, Pai RG. Echocardiographic predictors of pulmonary hypertension in patients with severe aortic stenosis. Eur J Echocardiogr 2008;9:31-3.
23. Zlotnick DM, Ouellette ML, Malenka DJ, et al. Effect of preoperative pulmonary hypertension on outcomes in patients with severe aortic stenosis following surgical aortic valve replacement. Am J Cardiol 2013;112:1635-40.
24. Melby SJ, Moon MR, Lindman BR, Bailey MS, Hill LL, Damiano RJ Jr. Impact of pulmonary hypertension on outcomes after aortic valve replacement for aortic valve stenosis. J Thorac Cardiovasc Surg 2011;141:1424-30.
25. O'Connor K, Magne J, Rosca M, Pierard LA, Lancellotti P. Impact of aortic valve stenosis on left atrial phasic function. Am J Cardiol 2010;106: 1157-62.
26. Malouf J, Enriquez-Sarano M, Pellikka P, et al. Severe pulmonary hypertension in patients with severe aortic valve stenosis: clinical profile and prognostic implications. J Am Coll Cardiol 2002; 40:78-95.
27. Cam A, Goel SS, Agarwal S, et al. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis. J Thorac Cardiovasc Surg 2011;142:800-8.
28. Pai RG, Varadarajan P, Kapoor N, Bansal RC. Aortic valve replacement improves survival in severe aortic stenosis associated with severe pulmonary hypertension. Ann Thorac Surg 2007; 84:80-5.
29. Lucon A, Oger E, Bedossa M, et al. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the FRANCE 2 registry. Circ Cardiovasc Interv 2014;7:240-7.
30. Lancellotti P, Magne J, Donal E, et al. Clinical outcome in asymptomatic severe aortic stenosis: insights from the new proposed aortic stenosis grading classification. J Am Coll Cardiol 2012;59: 235-43.
31. Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2451-96.
32. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014;63: 2438-88.
33. Magne J, Lancellotti P, Pierard LA. Exercise testing in asymptomatic severe aortic stenosis. J Am Coll Cardiol Img 2014;7:188-99.
34. Lancellotti P, Lebois F, Simon M, Tombeux C, Chauvel C, Pierard LA. Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 2005;112:I377-82.
35. Marechaux S, Hachicha Z, Bellouin A, et al. Usefulness of exercise-stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J 2010;31:1390-7.
36. Fawzy ME, Hassan W, Stefadouros M, Moursi M, El Shaer F, Chaudhary MA. Prevalence and fate of severe pulmonary hypertension in 559 consecutive patients with severe rheumatic mitral stenosis undergoing mitral balloon valvotomy. J Heart Valve Dis 2004;13:942-7.
37. Nunes MC, Hung J, Barbosa MM, et al. Impact of net atrioventricular compliance on clinical outcome in mitral stenosis. Circ Cardiovasc Imaging 2013;6:1001-8.
38. Kim HK, Kim YJ, Hwang SJ, et al. Hemodynamic and prognostic implications of net atrioventricular compliance in patients with mitral stenosis. J Am Soc Echocardiogr 2008;21:482-6.
39. Maoqin S, Guoxiang H, Zhiyuan S, et al. The clinical and hemodynamic results of mitral balloon valvuloplasty for patients with mitral stenosis complicated by severe pulmonary hypertension. Eur J Intern Med 2005;16:413-8.
40. Fawzy ME, Osman A, Nambiar V, et al. Immediate and long-term results of mitral balloon valvuloplasty in patients with severe pulmonary hypertension. J Heart Valve Dis 2008;17:485-91.
41. Ward C, Hancock B. Extreme pulmonary hypertension caused by mitral valve disease: natural history and results of surgery. Br Heart J 1975;37:74-8.
42. Li M, Déry JP, Dumesnil JG, Boudreault JR, Jobin J, Pibarot P. Usefulness of measuring net atrioventricular compliance by Doppler echocardiography in patients with mitral stenosis. Am J Cardiol 2005;96:432-5.
43. Brochet E, Detaint D, Fondard O, et al. Early hemodynamic changes versus peak values: what is more useful to predict occurrence of dyspnea during stress echocardiography in patients with asymptomatic mitral stenosis? J Am Soc Echocardiogr 2011;24:392-8.
44. Ribeiro PA, al Zaibag M, Abdullah M. Pulmonary artery pressure and pulmonary vascular resistance before and after mitral balloon valvotomy in 100 patients with severe mitral valve stenosis. Am Heart J 1993;125:1110-4.
45. Hirshfeld JW Jr., Epstein SE, Roberts AJ, Glancy DL, Morrow AG. Indices predicting longterm survival after valve replacement in patients with aortic regurgitation and patients with aortic stenosis. Circulation 1974;50:1190-9.
46. Naidoo DP, Mitha AS, Vythilingum S, Chetty S. Pulmonary hypertension in aortic regurgitation: early surgical outcome. Q J Med 1991;80:589-95.
47. Khandhar S, Varadarajan P, Turk R, et al. Survival benefit of aortic valve replacement in patients with severe aortic regurgitation and pulmonary hypertension. Ann Thorac Surg 2009; 88:752-6.
48. Le Tourneau T, Richardson M, Juthier F, et al. Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart 2010;96: 1311-7.
49. Magne J, Lancellotti P, Pierard LA. Exerciseinduced changes in degenerative mitral regurgitation. J Am Coll Cardiol 2010;56:300-9.
50. Magne J, Lancellotti P, O'Connor K, Van de Heyning CM, Szymanski C, Pierard LA. Prediction of exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. J Am Soc Echocardiogr 2011;24:1004-12.
51. Ghoreishi M, Evans CF, deFilippi CR, et al. Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. J Thorac Cardiovasc Surg 2011;142:1439-52.
52. Barbieri A, Bursi F, Grigioni F, et al. Prognostic and therapeutic implications of pulmonary hypertension complicating degenerative mitral regurgitation due to flail leaflet: a multicenter long-term international study. Eur Heart J 2011; 32:751-9.
53. Yang H, Davidson WR Jr., Chambers CE, et al. Preoperative pulmonary hypertension is associated with postoperative left ventricular dysfunction in chronic organic mitral regurgitation: an echocardiographic and hemodynamic study. J Am Soc Echocardiogr 2006;19:1051-5.
54. Kusunose K, Popovic ZB, Motoki H, Marwick TH. Prognostic significance of exercise induced right ventricular dysfunction in asymptomatic degenerative mitral regurgitation. Circ Cardiovasc Imaging 2013;6:167-76.
55. Magne J, Donal E, Mahjoub H, et al. Impact of exercise pulmonary hypertension on postoperative outcome in primary mitral regurgitation. Heart 2014 Oct 17 [E-pub ahead of print].
56. Lancellotti P, Rosenhek R, Pibarot P, et al. ESC Working Group on Valvular Heart Disease Position Paper-heart valve clinics: organization, structure, and experiences. Eur Heart J 2013;34:1597-606.
57. Marechaux S, Neicu DV, Braun S, et al. Functional mitral regurgitation: a link to pulmonary hypertension in heart failure with preserved ejection fraction. J Card Fail 2011;17:806-12.
58. Kainuma S, Taniguchi K, Toda K, et al. Pulmonary hypertension predicts adverse cardiac events after restrictive mitral annuloplasty for severe functional mitral regurgitation. J Thorac Cardiovasc Surg 2011;142:783-92.
59. Miller WL, Mahoney DW, Enriquez-Sarano M. Quantitative Doppler-echocardiographic imaging and clinical outcomes with left ventricular systolic dysfunction: independent impact of pulmonary hypertension. Circ Cardiovasc Imaging 2014;7: 330-6.
60. Enriquez-Sarano M, Rossi A, Seward JB, Bailey KR, Tajik AJ. Determinants of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol 1997;29:153-9.
61. Abramson S, Burke J, Kelly JJ. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 1992;116:888-95.
62. Costard-Jackle A, Fowler M. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 1992;19:48-54.
63. Agricola E, Stella S, Gullace M, et al. Impact of functional tricuspid regurgitation on heart failure and death in patients with functional mitral regurgitation and left ventricular dysfunction. Eur J Heart Fail 2012;14:902-8.
64. Giga V, Ostojic M, Vujisic-Tesic B, et al. Exercise-induced changes in mitral regurgitation in patients with prior myocardial infarction and left ventricular dysfunction: relation to mitral deformation and left ventricular function and shape. Eur Heart J 2005;26:1860-5.
65. Ennezat PV, Marechaux S, Huerre C, et al. Exercise does not enhance the prognostic value of Doppler echocardiography in patients with left ventricular systolic dysfunction and functional mitral regurgitation at rest. Am Heart J 2008;155: 752-7.
66. Lancellotti P, Gerard PL, Pierard LA. Longterm outcome of patients with heart failure and dynamic functional mitral regurgitation. Eur Heart J 2005;26:1528-32.
67. Pierard LA, Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema.NEngl JMed2004;351:1627-34.
68. Lancellotti P, Magne J. Stress echocardiography in regurgitant valve disease. Circ Cardiovasc Imaging 2013;6:840-9.
69. Magne J, Sénéchal M, Mathieu P, Dumesnil JG, Dagenais F, Pibarot P. Restrictive annuloplasty for ischemic mitral regurgitation may induce functional mitral stenosis. J Am Coll Cardiol 2008;51: 1692-701.
70. Fino C, Iacovoni A, Ferrero P, et al. Restrictive mitral valve annuloplasty versus mitral valve replacement for functional ischemic mitral regurgitation: an exercise echocardiographic study. J Thorac Cardiovasc Surg 2014;148:447-53.
71. Kainuma S, Taniguchi K, Daimon T, et al. Does stringent restrictive annuloplasty for functional mitral regurgitation cause functional mitral stenosis and pulmonary hypertension? Circulation 2011;124:S97-106.
72. Lam BK, Chan V, Hendry P, et al. The impact of patient-prosthesis mismatch on late outcomes after mitral valve replacement. J Thorac Cardiovasc Surg 2007;133:1464-73.
73. Magne J, Mathieu P, Dumesnil JG, et al. Impact of prosthesis-patient mismatch on survival after mitral valve replacement. Circulation 2007;115: 1417-25.
74. Acker MA, Parides MK, Perrault LP, et al. Mitralvalve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med 2014;370:23-32.
75. Bergler-Klein JK, Klaar U, Rosenhek R, et al. Prognostic value of natriuretic peptides in asymptomatic and symptomatic severe aortic stenosis (abstr). Circulation 2002;106:II-640.
76. Detaint D, Messika-Zeitoun D, Avierinos JF, et al. B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome. Circulation 2005;111:2391-7.
77. Magne J, Mahjoub H, Pierard LA, et al. Prognostic importance of brain natriuretic peptide and left ventricular longitudinal function in asymptomatic degenerative mitral regurgitation. Heart 2012;98:584-91.
78. Magne J, Mahjoub H, Pibarot P, Pirlet C, Pierard LA, Lancellotti P. Prognostic importance of exercise brain natriuretic peptide in asymptomatic degenerative mitral regurgitation. Eur J Heart Fail 2012;14:1293-302.
79. Lancellotti P, Cosyns B, Pierard LA. Dynamic left ventricular dyssynchrony contributes to B-type natriuretic peptide release during exercise in patients with systolic heart failure. Europace 2008;10:496-501.
80. Paulin R, Courboulin A, Meloche J, et al. Signal transducers and activators of transcription-3/pim1 axis plays a critical role in the pathogenesis of human pulmonary arterial hypertension. Circulation 2011;123:1205-15.
81. Renard S, Paulin R, Breuils-Bonnet S, et al. Pim-1: a new biomarker in pulmonary arterial hypertension. Pulm Circ 2013;3:74-81.
82. Tracy GP, Proctor MS, Hizny CS. Reversibility of pulmonary artery hypertension in aortic stenosis after aortic valve replacement. Ann Thorac Surg 1990;50:89-93.
83. Li M, Dumesnil JG, Mathieu P, Pibarot P. Impact of valve prosthesis-patient mismatch on pulmonary arterial pressure after mitral valve replacement. J Am Coll Cardiol 2005;45:1034-40.
84. Johnson LW, Hapanowicz MB, Buonanno C, Bowser MA, Marvasti MA, Parker FB Jr. Pulmonary hypertension in isolated aortic stenosis: hemodynamic correlations and follow-up. J Thorac Cardiovasc Surg 1988;95:603-7.
85. Ennezat PV, Marechaux S, Bouabdallaoui N, Le Jemtel TH. Dynamic nature of pulmonary artery systolic pressure in decompensated heart failure with preserved ejection fraction: role of functional mitral regurgitation. J Card Fail 2013;19:746-52.